Diagnostic utility of von Hippel-Lindau gene product, maspin, IMP3, and S100P in adenocarcinoma of the gallbladder

Human Pathology

Volumn 44, Issue 4, 2013, Pages 503-511

  Shi, Jianhui ^a   Liu, Haiyan ^a   Wang, Hanlin L ^a   Prichard, Jeffrey W ^a   Lin, Fan ^a  

^a GEISINGER MEDICAL CENTER   (United States)

Author keywords

Adenocarcinoma; Gallbladder; IMP3; Maspin; pVHL; S100P

Indexed keywords

IMP3 PROTEIN; MASPIN; PROTEIN S 100; UNCLASSIFIED DRUG; VON HIPPEL LINDAU PROTEIN;

ARTICLE; CANCER DIAGNOSIS; CONTROLLED STUDY; DIAGNOSTIC VALUE; DISEASE MARKER; GALLBLADDER ADENOCARCINOMA; GALLBLADDER CARCINOMA; GENE PRODUCT; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; MAJOR CLINICAL STUDY; PROTEIN EXPRESSION; STAINING; UPREGULATION;

ADENOCARCINOMA; CALCIUM-BINDING PROTEINS; CHOLECYSTITIS; CHRONIC DISEASE; DIAGNOSIS, DIFFERENTIAL; GALLBLADDER NEOPLASMS; HUMANS; NEOPLASM PROTEINS; RNA-BINDING PROTEINS; SERPINS; TUMOR MARKERS, BIOLOGICAL; VON HIPPEL-LINDAU TUMOR SUPPRESSOR PROTEIN;

EID: 84875214295     PISSN: 00468177     EISSN: 15328392     Source Type: Journal    
DOI: 10.1016/j.humpath.2012.06.010     Document Type: Article

References (27)

1. D. Weedon Pathology of the gallbladder Masson Monographs in Diagnostic Pathology, No 8, 1st edition 1984 Masson Publishers USA New York
2. J. Albores-Saavedra, D.E. Henson, and D.S. Klimstra Tumors of the gallbladder, extrahepatic bile ducts, and ampulla of vater, 3rd series, fascicle 27 2000 Armed Forces Institute of Pathology Washington, DC
3. D.A. Owen, and J.K. Kelly Neoplasms of the gallbladder D.A. Owen, J.K. Kelly, Pathology of the gallbladder, biliary tract and pancreas 1st ed 2001 WB Saunders Philadelphia 286 310
4. D.E. Hensen, J. Albores-Saavedra, and D. Corle Carcinoma of the gallbladder. Histologic types, stage of disease and survival rates Cancer 70 1992 1493 1497
5. H.J. Choi, S.S. Yun, H.J. Kim, and J.H. Choi Expression of p16 protein in gallbladder carcinoma and its precancerous conditions Hepatogastroenterology 57 2010 18 21
6. H. Tamura, M. Ohtsuka, and M. Washiro Reg IV expression and clinicopathologic features of gallbladder carcinoma Hum Pathol 40 2009 1686 1692
7. M.O. Riener, A. Vogetseder, and B.C. Pestalozzi Cell adhesion molecules P-cadherin and CD24 are markers for carcinoma and dysplasia in the biliary tract Hum Pathol 41 2010 1558 1565
8. Q.L. Li, Z.L. Yang, J.Q. Liu, and X.Y. Miao Expression of CDX2 and hepatocyte antigen in benign and malignant lesions of gallbladder and its correlation with histopathologic type and clinical outcome Pathol Oncol Res 17 2011 561 568
9. M. Kaufman, B. Mehrotra, and S. Limaye EGFR expression in gallbladder carcinoma in North America Int J Med Sci 5 2008 285 291
10. S. Prince, A. Zeidman, Y. Dekel, E. Ram, and R. Koren Expression of epithelial cell adhesion molecule in gallbladder carcinoma and its correlation with clinicopathologic variables Am J Clin Pathol 129 2008 424 429
11. Z. Németh, A.M. Szász, and P. Tátrai Claudin-1, -2, -3, -4, -7, -8, and -10 protein expression in biliary tract cancers J Histochem Cytochem 57 2009 113 121
12. W. Wu, R. Wang, and H. Liu Prediction of prognosis in gallbladder carcinoma by CD147 and MMP-2 immunohistochemistry Med Oncol 26 2009 117 123
13. H. Kirimlioǧlu, I. Türkmen, N. Başsüllü, A. Dirican, N. Karadaǧ, and V. Kirimlioǧlu The expression of matrix metalloproteinases in intrahepatic cholangiocarcinoma, hilar (Klatskin tumor), middle and distal extrahepatic cholangiocarcinoma, gallbladder cancer, and ampullary carcinoma: role of matrix metalloproteinases in tumor progression and prognosis Turk J Gastroenterol 20 2009 41 47
14. J.F. Mosnier, C. Kandel, and D. Cazals-Hatem N-cadherin serves as diagnostic biomarker intrahepatic and perihilar cholangiocarcinomas Mod Pathol 22 2009 182 190
15. J.Y. Sung, G.Y. Kim, S.J. Lim, Y.K. Park, and Y.W. Kim Expression of the GLUT1 glucose transporter and p53 in carcinomas of the pancreatobiliary tract Pathol Res Pract 206 2010 24 29
16. M. Legan, S. Tevžič, A. Tolar, B. Luzar, and V.F. Marolt Glucose transporter-1 (GLUT-1) immunoreactivity in benign, premalignant and malignant lesions of the gallbladder Pathol Oncol Res 17 2011 61 66
17. C. Maesawa, S. Ogasawara, and A. Yashima-Abo Aberrant maspin expression in gallbladder epithelium is associated with intestinal metaplasia in patients with cholelithiasis J Clin Pathol 59 2006 328 330
18. J. Kim, K.T. Jang, and K.H. Kim Aberrant maspin expression is involved in early carcinogenesis of gallbladder cancer Tumour Biol 31 2010 471 476
19. F. Lin, J. Shi, and H. Liu Diagnostic utility of S100P and von Hippel-Lindau gene product (pVHL) in pancreatic adenocarcinoma-with implication of their roles in early tumorigenesis Am J Surg Pathol 32 2008 78 91
20. H. Deng, J. Shi, M. Wilkerson, S. Meschter, W. Dupree, and F. Lin Usefulness of S100P in diagnosis of adenocarcinoma of pancreas on fine-needle aspiration biopsy specimens Am J Clin Pathol 129 2008 81 88
21. H. Liu, J. Shi, and V. Anandan Reevaluation and identification of the best immunohistochemical panel (pVHL, maspin, S100P, IMP-3) for adenocarcinoma of the pancreas Arch Pathol Lab Med 136 2012 601 609
22. M. Levy, F. Lin, H. Xu, D. Dhall, B.O. Spaulding, and H.L. Wang S100P, von Hippel-Lindau gene product, and IMP3 serve as a useful immunohistochemical panel in the diagnosis of adenocarcinoma on endoscopic bile duct biopsy Hum Pathol 41 2010 1210 1219
23. M. Schmidt, F. Chung, F. Lin, H. Xu, and H.L. Wang Use of S100P, IMP3 and pVHL immunopanel to aid in the interpretation of bile duct biopsies with atypical histology or suspicious for malignancy Mod Pathol 24 Suppl. 1 2011 374A USCAP Abstract #1586
24. F. Lin, J. Shi, H.L. Wang, and H. Liu Diagnostic utility of von Hippel-Lindau gene product (pVHL), maspin, KOC, and S100P in adenocarcinoma of the gallbladder Mod Pathol 23 Suppl. 1 2010 363A USCAP Abstract #1612
25. F. Lin, J. Shi, H. Liu, J.W. Prichard, and H.L. Wang CK17, MUC5AC, pVHL, and S100P are the effective antibody panel in differentiating intrahepatic cholangiocarcinoma from pancreatic adenocarcinoma Mod Path 24 Suppl. 1 2011 367A USCAP Abstract #1556
26. F. Lin, H.L. Wang, M. Wilkerson, and H. Liu Utility of pVHL, maspin, S100P and IMP3 in diagnosis of carcinomas from various organs Mod Pathol 24 Suppl. 1 2011 367A USACP Abstract #1557
27. F. Lin, J. Shi, and H. Liu Immunohistochemical detection of the von Hippel-Lindau gene product (pVHL) in human tissues and tumors: a useful marker for metastatic renal cell carcinoma and clear cell carcinoma of the ovary and uterus Am J Clin Pathol 129 2008 592 605